|  |  | 

India Top Headlines

Pvt Labs with USFDA Approved Kits Can Begin Testing Covid-19 | India News


NEW DELHI: The government has decided that private laboratories with Covid-19 test kits approved by the US Food and Drug Administration. USA (US FDA) They can start testing suspicious cases, significantly increasing the scope and number of people being tested. The cost of such tests will also be specified.

Until now, government labs have carried out the tests and even this number has risen to 111, an increase from about 70 or so who were involved in the Covid-19 tests until a few days ago. Allowing private labs, about 50 initially, will also help address criticism that too little testing is underway.

More about Covid-19

The government has expanded the testing criteria to all hospitalized pneumonia cases beyond randomized testing of ICU patients. The test had been restricted to people complaining of Covid-19 symptoms with a history of foreign travel from whom they came in contact with those people.

Meanwhile, ICMR said that community transmission of the disease has yet to be documented. He added that the testing strategy would be further changed if there is evidence of a community spread.

While allowing private laboratories to do tests, the Center said Saturday they can do so based on a prescription from a registered doctor and according to test guidelines and protocols issued by the Indian Council for Medical Research (ICMR). US FDA approval. USA For kits it is the key criterion, apart from the SOPs for the biosecurity of the samples and the collection procedures.

“We have reached a decision on allowing private laboratories. The order detailing eligibility to participate in the program and the cost of such tests performed by private laboratories will be issued overnight, “a senior official told TOI. The government has increased its network with 111 public sector laboratories that they now offer Covid-19 testing nationwide.

“Private labs will be guided by testing protocols and criteria established by ICMR,” said joint secretary of the health ministry, Lav Agarwal, emphasizing that testing should not be “out of date” or “an exercise in promoting the trust”.

Meanwhile, test protocols were also revised on Friday to include all hospitalized patients with severe acute respiratory illness (fever and cough and / or shortness of breath). He also said that the “direct, high-risk asymptomatic contacts” of a confirmed case should be tested once between day 5 and day 14 of contact.

According to the notice, direct, high-risk contacts include those living in the same household with a confirmed case and health workers who examined a confirmed case without adequate protection.

The government kept most of the Covid-19 cases in India so far related to travel and local transmission of imported cases to its immediate contacts. “The test protocol is based on a response according to the evolution of the situation. Public health experts take note of the evolution of the situation, discuss it and then make the corresponding decisions, “said Agarwal.

Increasing preparedness for a potential influx of patients, the government also launched critical care management training at 1,000 locations through a video conference, and said it would conduct a nationwide simulation drill on Sunday for an emergency response. to manage coronavirus cases.

The government has also instructed states to increase the production and supply of masks and disinfectants by removing permits to increase the capacity of existing disinfectant manufacturing units. Similarly, deodorant manufacturers have been asked to produce disinfectants to meet growing demand. Alcohol manufacturers have also been asked to supply the raw material, and also set up units on their own if possible.

The government also set the prices of masks and disinfectants under the Commodities Act to avoid overpricing for these products. While the 2 and 3 layer masks have a maximum retail price of Rs 8 and Rs 10 per piece, respectively, the price of a 200ml disinfectant unit has been set at Rs 100.

Original source